Stock Charts
WallstreetSelect
Symbol Lookup

WallStreetSelect 114
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
United Therapeutics Corp (NQ: UTHR)
68.47 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 4:00 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Blog posts about United Therapeutics Corp
 
< Previous 1 2 Next >
Stock Losers: Lake Shore Gold Corp Ordinary Shares, Synaptics, Incorporated, United Therapeutics Corporation, HollyFrontier Corp
April 26, 2013
Dallas, TX -- (SBWIRE) -- 04/26/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
(UTHR) United Therapeutics Corporation to Move Pluristem Therapeutics Drug into Phase I
April 21, 2013
United Therapeutics Corporation (UTHR) recently gained approval for the commencement of a phase I... Visit StockBlogHub to view complete post. Read More
category UTHR , QLTI , QLT Inc , and 5 more.
from Stock Blog Hub
Top Stocks: Pharmacyclics, United Therapeutics Corporation, the Medicines Company, Cubist Pharmaceuticals Inc
March 27, 2013
Lakeway, TX -- (SBWIRE) -- 03/27/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Stocks in Focus: Gold Fields Limited, United Therapeutics, Red Hat, Pengrowth Energy
March 25, 2013
Lakeway, TX -- (SBWIRE) -- 03/25/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Stocks to Watch: Otelco, United Therapeutics, PGT, Vodafone Group
March 25, 2013
Lakeway, TX -- (SBWIRE) -- 03/25/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
US Stocks Alert: United Therapeutics Corporation, EXACT Sciences Corporation, MELA Sciences Inc, Varian Medical Systems
March 20, 2013
Lakeway, TX -- (SBWIRE) -- 03/20/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Stocks in Focus: United Therapeutics Corporation, Cubist Pharmaceuticals Inc, Depomed Inc, DURECT Corporation
March 12, 2013
Lakeway, TX -- (SBWIRE) -- 03/12/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Drug Manufacturers Stocks Alert: Prana Biotechnology Limited, the Medicines Company, Forest Laboratories, United Therapeutics Corporation
March 07, 2013
Lakeway, TX -- (SBWIRE) -- 03/07/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Traders Alert: Tenet Healthcare Corporation, Trina Solar Limited, United Therapeutics Corporation
February 27, 2013
Lakeway, NY -- (SBWIRE) -- 02/27/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... Read More
from SBWire - Latest Press Releases
Top Movers: United Therapeutics, ONEOK Partners, Cablevision, Atmel
February 26, 2013
Lakeway, NY -- (SBWIRE) -- 02/26/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... Read More
from SBWire - Latest Press Releases
Volume Buzz: United Therapeutics, Applied Materials, Amgen, Agrium
February 26, 2013
Lakeway, NY -- (SBWIRE) -- 02/26/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... Read More
from SBWire - Latest Press Releases
(MAA) Revenues Rise at Endocyte
February 26, 2013
Endocyte, Inc. (ECYT) reported fourth quarter 2012 net loss per share of 2 cents, in line with the... Visit StockBlogHub to view complete post. Read More
category REIT / Residential , Lannett Company Inc , UTHR , and 9 more.
from Stock Blog Hub
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and United Therapeutics Corporation (NASDAQ:UTHR) Added to Growing Stock Report's NASDAQ Gainers Watch List.
February 26, 2013
New York, NY -- (SBWIRE) -- 02/26/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and United Therapeutics... Read More
from SBWire - Latest Press Releases
NASDAQ Gainers Watch List: United Therapeutics Corporation (NASDAQ:UTHR) and Leap Wireless International Inc. (NASDAQ:LEAP) Added to Growing Stock Report's NASDAQ Gainers Watch List
February 15, 2013
New York, NY -- (SBWIRE) -- 02/15/2013 -- Growing Stock Report expands its NASDAQ Gainers Watch List today adding United Therapeutics Corporation (NASDAQ:UTHR) and Leap Wireless International Inc.... Read More
from SBWire - Latest Press Releases
Oasis Petroleum Inc. (NYSE:OAS) Surges 2.61%: FIG, IGT, UTHR, OAS
February 06, 2013
Lakeway, TX -- (SBWIRE) -- 02/06/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
(UTHR) United Therapeutics Reiterated at Neutral
January 02, 2013
We recently reiterated a Neutral recommendation on United Therapeutics (UTHR). While the company... Visit StockBlogHub to view complete post. Read More
category VRX , Valeant Pharmaceuticals International , UTHR , and 7 more.
from Stock Blog Hub
(MAA) Actelion Drug Accepted for Review
December 24, 2012
Switzerland-based Actelion (ALIOF) recently announced that the US Food and Drug Administration... Visit StockBlogHub to view complete post. Read More
category REIT / Residential , UTHR , MAA , and 5 more.
from Stock Blog Hub
Top Losers in After-Hours Today (NFX, TPX, UTHR, UIS)
October 25, 2012
Los Angelas, CA -- (SBWIRE) -- 10/25/2012 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks.... Read More
from SBWire - Latest Press Releases
United Therapeutics Skeptics Cash In Their Chips
October 24, 2012
The shares of United Therapeutics Corporation (NASDAQ:UTHR - 46.24) are sitting out the broad-market rebound, with the stock last seen more than 13% lower...( Read More ) Read More
category UTHR
from SchaeffersResearch.com Daily Market Blog
(ARNA) Arena Pharmaceuticals Initiates PAH Study
October 23, 2012
Arena Pharmaceuticals, Inc. (ARNA) recently initiated a phase I multiple dose study with APD811,... Visit StockBlogHub to view complete post. Read More
category Glaxosmithkline plc , UTHR , Drug Manufacturers / Other , and 7 more.
from Stock Blog Hub
The Best Health Care Stock for 2013
October 22, 2012
A measly $1,000 investment in this medical company in January 2004 would be worth $2.8 million right now... and that amount could double again in the next few years. Read More
from Wealth Daily
SPX & NDX Edge Higher in Mixed, Volatile Session
October 02, 2012
The stock market indices suffered early losses, and at one point late in the afternoon, after they bounced and started to get through the highs, they sold off very sharply in a 5-wave decline. By late... Read More
from Harry's Hotline by Harry Boxer
United Therapeutics Corp. (UTHR) – Bull of the Day
September 28, 2012
United Therapeutics Corp.'s (UTHR) second quarter earnings of $1.43 per share were well above the year-ago earnings of $1.19 and the Zacks Consensus Estimate of $1.12. Higher revenues led to the... Read More
category Zacks , Syndicated Content
from Money Morning
(PFE) Pharma and Biotech Stock Outlook – August 2012 – Industry Outlook
August 10, 2012
The pharmaceutical industry is in the midst of one of the biggest patent cliffs with Pfizer’s (PFE)... Visit StockBlogHub to view complete post. Read More
category Mylan Inc/ , Glaxosmithkline plc , Gladstone Investment Corporation , and 59 more.
from Stock Blog Hub
(UTHR) United Therapeutics Corporation – Bull of the Day
August 02, 2012
United Therapeutics Corp.’s (UTHR) second quarter earnings of $1.43 per share were well above... Visit StockBlogHub to view complete post. Read More
category United Therapeutics Corporation , Healthcare , UTHR , and 1 more.
from Stock Blog Hub
Upgrades & Downgrades
April 12, 2012
New York, April 12th (TradersHuddle.com) - Research Calls ahead of the market open. AT&T ( NYSE:T ) was upgraded to Overweight from Neutral at JPMorgan. Canadian Pacific (<a href="http://ww. Read More... Read More
from TradersHuddle.com
Neutral On United Therapeutics
March 30, 2012
We recently reiterated our Neutral recommendation on United Therapeutics (NASDAQ:UTHR). United Therapeutics is focused on the development and commercialization of therapeutic products for patients with... Read More
category NVS , UTHR , Stocks , and 3 more.
from DailyMarkets.com
UTHR Files Suit Vs. Sandoz
March 16, 2012
United Therapeutics Corporation (NASDAQ:UTHR) recently filed a patent infringement lawsuit against Sandoz, Novartis’ (NYSE:NVS) generic unit, which is seeking approval for its generic version of... Read More
category NVS , UTHR , Stocks , and 2 more.
from DailyMarkets.com
Action Date For UTHR Candidate
February 24, 2012
United Therapeutics Corporation (NASDAQ:UTHR) recently announced that its new drug application (NDA) for oral treprostinil was accepted for review by the US Food and Drug Administration (FDA). The... Read More
category UTHR , Stocks , External Research , and 3 more.
from DailyMarkets.com
UTHR Misses Expectations
February 15, 2012
United Therapeutics Corp. (NASDAQ:UTHR) reported fourth-quarter earnings of 77 cents per share, well above the year-ago earnings of 23 cents but below the Zacks Consensus Estimate of 87 cents. Higher... Read More
category NVS , UTHR , Stocks , and 2 more.
from DailyMarkets.com
< Previous 1 2 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

©2009 WALL STREET SELECT | Online Media Select, LLC | Privacy Policy | Terms | Advertise | Contact Us